Changes in delusional dimensions and emotions over eight weeks of antipsychotic treatment in acute patients
Suzanne H So, Emmanuelle R Peters, Shitij Kapur, Philippa A Garety
Psychiatry Research | ELSEVIER IRELAND LTD | Published : 2015
Awarded by Medical Research Council
This work was supported by the Croucher Foundation Scholarship and the University of London Central Research Fund to SS. SK receives grant support from AstraZeneca, Bristol-Myers (BMS) and Glaxo Smith Kline. He is a consultant/speaker/advisor for the following companies: AstraZeneca, Bioline, Bristol Meyers Squibb, Eli Lilly, Janssen (Johnson and Johnson), Lundbeck, Otsuka, Organon, Pfizer, Servier, Solvay Wyeth. PG, SK and EP acknowledge support for some clinical sessions from the National Institute of Health Research (NIHR) Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology and Neuroscience, King's College London.